TB-500

TB-500 (Thymosin Beta-4 Fragment)

What is it? TB-500 is a synthetic peptide based on a naturally occurring protein called thymosin beta-4, which is involved in tissue repair and cell movement. It has been studied primarily in animal and laboratory research and is not approved for human therapeutic use by Health Canada or the FDA.

Potential Research Benefits

May support muscle recovery

May promote tendon and ligament repair

May aid flexibility and mobility during recovery

May support wound healing

May help reduce inflammation in preclinical studies

May promote new blood vessel formation (angiogenesis)

May support recovery from soft tissue injuries

Typical Research Cycle

Cycle Length: 6–8 weeks

Common Research Dose: 2–5 mg per week

Research protocols often divide the weekly amount into 2–3 administrations per week.

Some protocols use a higher initial "loading" period followed by a lower maintenance amount, though approaches vary.

Storage

Refrigerate after reconstitution (2–8°C)

Protect from light

Use within approximately 28 days after mixing (following sterile handling practices)